Peggy Papeleu
- Molecular Biology top 10%
- Hepatology top 2%
- Surgery top 10%
- Oncology
- Pharmacology top 5%
- Co-authors
- Vera RogiersTamara VanhaeckeGreetje ElautMathieu VinkenSarah SnykersTom HenkensJames Kevin ChipmanJean‐Baptiste Watelet
- Topics
- Histone Deacetylase Inhibitors Research (11 papers)Liver physiology and pathology (10 papers)Pancreatic function and diabetes (7 papers)
- Partner nations
- BelgiumFranceUnited Kingdom
In The Last Decade
Peggy Papeleu
30 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 99
- Molecular Biology 957
- Hepatology 378
- Surgery 298
- Oncology 172
- Pharmacology 155
Countries citing papers authored by Peggy Papeleu
This map shows the geographic impact of Peggy Papeleu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peggy Papeleu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peggy Papeleu more than expected).
Fields of papers citing papers by Peggy Papeleu
This network shows the impact of papers produced by Peggy Papeleu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peggy Papeleu. The network helps show where Peggy Papeleu may publish in the future.
Co-authorship network of co-authors of Peggy Papeleu
This figure shows the co-authorship network connecting the top 25 collaborators of Peggy Papeleu. A scholar is included among the top collaborators of Peggy Papeleu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peggy Papeleu. Peggy Papeleu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 32 | |
| 2 | 112 | |
| 3 | In vitro multipotency of human bone marrow (mesenchymal) stem cells | 2 |
| 4 | 54 | |
| 5 | 13 | |
| 6 | 93 | |
| 7 | 8 | |
| 8 | 8 | |
| 9 | 83 | |
| 10 | 38 | |
| 11 | 3 | |
| 12 | 44 | |
| 13 | 53 | |
| 14 | 197 | |
| 15 | 0 | |
| 16 | 208 | |
| 17 | 20 | |
| 18 | 3 | |
| 19 | 52 | |
| 20 | Practical aspects of in vitro biotransformation studies during early drug development | 3 |
About Peggy Papeleu
Peggy Papeleu is a scholar working on Hepatology, Molecular Biology and Genetics, having authored 31 papers that have together received 1.6k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (11 papers), Liver physiology and pathology (10 papers) and Pancreatic function and diabetes (7 papers). The work is most often cited by research in Hepatology (378 citations), Pharmacology (155 citations) and Molecular Biology (957 citations). Peggy Papeleu has collaborated with scholars based in Belgium, France and United Kingdom. Frequent co-authors include Vera Rogiers, Tamara Vanhaecke, Greetje Elaut, Mathieu Vinken, Sarah Snykers, Tom Henkens, James Kevin Chipman, Jean‐Baptiste Watelet, François‐Xavier Mathy and Rhys Whomsley. Their work appears in journals such as Hepatology, Journal of Hepatology and Toxicology and Applied Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.